Angina Market Set To Expand From $14.84 Billion In 2026: Growth Outlook Through 2030
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Angina Market Value Growth And Long-Term Outlook
The angina market has experienced significant expansion in recent years. It is anticipated to increase from $11.36 billion in 2025 to $12.05 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.1%. Historically, this growth can be primarily attributed to factors such as the rising prevalence of cardiovascular diseases, the availability of beta blockers and nitrates, the expansion of hospital cardiac care units, increased diagnostic testing, and the growth of cardiology specialty care.
The angina market is anticipated to exhibit robust growth over the next few years, with its size projected to reach $14.84 billion by 2030, expanding at a compound annual growth rate (CAGR) of 5.3%. This expansion during the forecast period can be attributed to the escalating demand for personalized cardiovascular treatment, the increasing application of minimally invasive cardiac procedures, the rising adoption of digital cardiac monitoring solutions, the expansion of preventive cardiology programs, and continuous advancements in cardiovascular drug development. Prominent trends within the forecast period include the increasing uptake of combination drug therapies, a rise in the use of long-acting nitrates, an intensifying focus on preventive cardiac care, the broadening of interventional treatment options, and an enhanced emphasis on lifestyle and risk management.
Get A Free Sample Report With In-Depth Market Insights:
Angina Market Growth Backed By Core Demand Fundamentals
The growing incidence of cardiovascular diseases is projected to drive the expansion of the angina market in the coming years. These disorders pertain to the heart and blood vessels, encompassing conditions such as coronary heart disease, heart failure, and stroke. The escalating prevalence of cardiovascular diseases is largely spurred by aging populations and increased exposure to adjustable risk factors like unhealthy diets, sedentary lifestyles, and tobacco consumption. This increase in cardiovascular disease cases boosts the demand for angina treatments, as these conditions frequently manifest with chest pain that requires medical intervention to alleviate discomfort and prevent complications. For instance, in October 2024, data from the Centers for Disease Control and Prevention, a US-based government agency overseeing public health, indicated that cardiovascular disease deaths rose from 371,506 cases in 2022 to 919,032 deaths in 2023. Therefore, the increasing prevalence of cardiovascular diseases is propelling the growth of the angina market.
Angina Market Segments: Where Is Growth Concentrated?
The angina market covered in this report is segmented –
1) By Type: Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types
2) By Treatment: Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments
3) By Drug Class: Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes
4) By Application: Clinics, Hospitals, Other Applications
Subsegments:
1) By Angina Pectoris: Stable Angina, Chronic Stable Angina, Effort-Induced Angina, Variant Or Microvascular Angina
2) By Unstable Angina: Acute Unstable Angina, Pre-Infarction Angina, Rest Angina
3) By Prinzmetal Angina: Vasospastic Angina, Coronary Artery Spasm-Induced Angina, Variant Angina
4) By Other Types: Nocturnal Angina, Post-Infarction Angina, Angina With Silent Myocardial Ischemia, Angina Due To Aortic Stenosis Or Valve Disease
Angina Market Growth Trends Reshaping The Competitive Landscape
Companies operating within the angina market are developing novel medications, such as metoprolol tartrate tablets, to offer more effective and targeted treatments for patients with coronary artery disease (CAD) and related health issues. Metoprolol tartrate tablets are a type of drug frequently prescribed for various cardiovascular conditions, including angina (chest pain), hypertension (high blood pressure), and heart failure. For instance, in April 2023, Zydus, an India-based pharmaceutical company, obtained final approval from the United States Food and Drug Administration (US-FDA) to produce and sell its generic version of Metoprolol Tartrate Tablets USP in strengths of 25 mg, 50 mg, and 100 mg. Metoprolol, a beta blocker, is utilized for treating several cardiovascular conditions, such as high blood pressure (hypertension) and chest pain (angina), and for improving survival rates post-heart attack.
Angina Market Key Participants And Competitive Landscape
Major companies operating in the angina market are Pfizer Inc., Bayer AG, AstraZeneca PLC, Merck & Co Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Otsuka Pharmaceutical Co Ltd, Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Abbott Laboratories, Daiichi Sankyo Company Ltd, Takeda Pharmaceutical Company Limited, Cipla Limited, Sun Pharmaceutical Industries Ltd, Zydus Cadila Healthcare Ltd, Astellas Pharma Inc., Amarin Corporation, Torrent Pharmaceuticals Ltd
View The Full Angina Market Report:
Angina Market Regional Breakdown: Where Is Demand Concentrated?
North America was the largest region in the angina market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
